Amy Conrad | Investor Relations |
Erik Holmlin | Chief Executive Officer |
Alka Chaubey | Chief Medical Officer |
Chris Stewart | Chief Financial Officer |
Sung Ji Nam | BTIG |
Jeffrey Cohen | Ladenburg Thalmann |
Jason McCarthy | Maxim Group |
Susan Chor | Oppenheimer |
Good day, and welcome to the Bionano Genomics Second Quarter 2021 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. Please go ahead.
Thank you, Laura, and good afternoon, everyone.